• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number GSX0030A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Atrial Fibrillation (1729)
Event Date 12/07/2020
Event Type  Injury  
Manufacturer Narrative
The gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: new arrhythmia requiring treatment.
 
Event Description
The following information was obtained through the clinical study (b)(6): it was reported the physician implanted a gore® cardioform septal occluder on (b)(6) 2020.On (b)(6) 2020, the patient was noted to have a paroxysmal supraventricular tachycardia (psvt).The study site notes that treatment was provided by the health care professional but does not specify what.On (b)(6) 2020, echocardiography performed and beta blocker medication started along with holter monitor.
 
Manufacturer Narrative
Updated event description in section b.Added new patient code.
 
Event Description
It was reported the physician implanted a gore® cardioform septal occluder on (b)(6), 2020.On (b)(6), 2020, the patient was noted to have a paroxysmal supraventricular tachycardia (psvt).The study site notes that treatment was provided by the health care professional but does not specify what.On (b)(6) 2020, echocardiography performed and beta blocker medication started along with holter monitor.In the clinical data base the patient arrhythmia was updated to atrial fibrillation (b)(6), 2020, following holter monitor.Started subject on amiodarone and apixaban.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11108585
MDR Text Key224788436
Report Number2017233-2021-01567
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132631032
UDI-Public00733132631032
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 01/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/19/2022
Device Model NumberGSX0030A
Device Catalogue NumberGSX0030A
Was Device Available for Evaluation? No
Date Manufacturer Received12/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age38 YR
Patient Weight136
-
-